Results 181 to 190 of about 260,779 (356)

Unveiling unique protein and phosphorylation signatures in lung adenocarcinomas with and without ALK, EGFR, and KRAS genetic alterations

open access: yesMolecular Oncology, EarlyView.
Proteomic and phosphoproteomic analyses were performed on lung adenocarcinoma (LUAD) tumors with EGFR, KRAS, or EML4–ALK alterations and wild‐type cases. Distinct protein expression and phosphorylation patterns were identified, especially in EGFR‐mutated tumors. Key altered pathways included vesicle transport and RNA splicing.
Fanni Bugyi   +12 more
wiley   +1 more source

Expression analysis of protein inhibitor of activated STAT (PIAS) genes in IFNβ-treated multiple sclerosis patients

open access: yesJournal of Inflammation Research, 2018
Mohammad Taheri,1,* Ghazaleh Azimi,2,* Arezou Sayad,2 Mehrdokht Mazdeh,3 Shahram Arsang-Jang,4,5 Mir Davood Omrani,5 Soudeh Ghafori-Fard2 1Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 2Department of Medical ...
Taheri M   +6 more
doaj  

Combinatorial genetics in liver repopulation and carcinogenesis with a in vivo CRISPR activation platform†

open access: green, 2017
Kirk J. Wangensteen   +9 more
openalex   +1 more source

Peroxisome Proliferator-Activated Receptor-δ Genotype Influences Metabolic Phenotype and May Influence Lipid Response to Statin Therapy in Humans: A Genetics of Diabetes Audit and Research Tayside Study [PDF]

open access: bronze, 2010
Lindsay Burch   +9 more
openalex   +1 more source

Genetic toxicology and genetically active environmental factors

open access: yesInternational Journal of Biology and Chemistry, 2018
A. I. Zhussupova   +2 more
openaire   +2 more sources

Objectives and activities of the Genetic Alliance [PDF]

open access: yesAmerican Journal of Public Health, 2000
M E Davidson, J Weiss
openaire   +2 more sources

Targeting of PTP4A3 overexpression sensitises HGSOC cells towards chemotherapeutic drugs

open access: yesMolecular Oncology, EarlyView.
In HGSOC with normal KRAS expression, high PTP4A3 expression regulates autophagy activation. Conversely, in HGSOC with high KRAS expression, KRAS dictates autophagy control, and PTP4A3 is not required. When high PTP4A3 expression is inhibited, HGSOC cells are preferentially sensitised towards DNA‐damaging agents.
Ana López‐Garza   +3 more
wiley   +1 more source

Genetic evidence informs the direction of therapeutic modulation in drug development. [PDF]

open access: yesNPJ Drug Discov
Chen R   +10 more
europepmc   +1 more source

The Relationship between Peroxisome Proliferator-Activated Receptor-γ and Renin: A Human Genetics Study [PDF]

open access: bronze, 2010
Patricia Underwood   +11 more
openalex   +1 more source

Olaparib synergy screen reveals Exemestane induces replication stress in triple‐negative breast cancer

open access: yesMolecular Oncology, EarlyView.
Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy